If you or someone you love is facing a glioma, a type of brain tumor, you might hear about proton therapy. It's a precise form of radiation, and researchers are actively studying it. A new analysis looked at the 100 most-cited scientific articles on the topic to see where the field is heading. It found the United States has published the most, with Massachusetts General Hospital contributing the most papers. The work also identified key authors and spotted emerging topics scientists are focusing on, like using advanced computer simulations and studying long-term effects on thinking skills in childhood cancer survivors. It's important to understand what this analysis is and isn't. It's a map of the scientific conversation—a look at what researchers are writing and talking about most. It doesn't study patients directly, so it can't tell us if proton therapy is safer or more effective than other treatments for glioma. It simply shows us the landscape of the research itself.
Where is the research on proton therapy for brain tumors heading?
Photo by Philip Strong / Unsplash
What this means for you:
This maps research trends on proton therapy for brain tumors, not its effectiveness for patients. More on Glioma
High tumour mutation burden improves overall survival in solid tumours treated with immune checkpoint inhibitors High Mutation Counts May Predict Better Cancer Survival Outcomes
· May 1, 2026
Observational study identifies four immune subtypes in newly-diagnosed glioma grades 2-4 among 354 patients New immune map shows how glioma types affect survival chances
medRxiv · Apr 30, 2026
Narrative review suggests multi-omics AI models improve glioma radiotherapy response prediction over single-modality approaches. Glioma Radiotherapy Gets Smarter With Biomarker-Guided Dosing
Frontiers · Apr 27, 2026
Systematic review and meta-analysis of intra-arterial cerebral infusion for glioma patients Direct Drug Delivery May Help Brain Tumors
· Apr 23, 2026